Literature DB >> 9452499

SHP-1 associates with both platelet-derived growth factor receptor and the p85 subunit of phosphatidylinositol 3-kinase.

Z Yu1, L Su, O Hoglinger, M L Jaramillo, D Banville, S H Shen.   

Abstract

The Src homology 2 (SH2)-containing protein tyrosine phosphatase 1, SHP-1, is highly expressed in all hematopoietic cells as well as in many non-hematopoietic cells, particularly in some malignant epithelial cell lines. In hematopoietic cells, SHP-1 negatively regulates multiple cytokine receptor pathways. The precise function and the targets of SHP-1 in non-hematopoietic cells, however, are largely unknown. Here we demonstrate that SHP-1 associates with both the tyrosine-phosphorylated platelet-derived growth factor (PDGF) receptor and the p85 subunit of phosphatidylinositol 3-kinase in MCF-7 and TRMP cells. Through the use of mutant PDGF receptors and performing peptide competition for immunoprecipitation, it was determined that SHP-1 independently associates with the PDGF receptor and p85 and that its N-terminal SH2 domain is directly responsible for the interactions. Overexpression of SHP-1 in TRMP cells transfected with the PDGF receptor markedly inhibited PDGF-induced c-fos promoter activation, whereas the expression of three catalytically inactive SHP-1 mutants increased the c-fos promoter activation in response to PDGF stimulation. These results indicate that SHP-1 might negatively regulate PDGF receptor-mediated signaling in these cells. Identification of the association of SHP-1 with the PDGF receptor and p85 in MCF-7 and TRMP cells furthers our understanding of the function of SHP-1 in non-hematopoietic cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9452499     DOI: 10.1074/jbc.273.6.3687

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  mSiglec-E, a novel mouse CD33-related siglec (sialic acid-binding immunoglobulin-like lectin) that recruits Src homology 2 (SH2)-domain-containing protein tyrosine phosphatases SHP-1 and SHP-2.

Authors:  Z Yu; M Maoui; L Wu; D Banville; S Shen
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

2.  Site-selective regulation of platelet-derived growth factor beta receptor tyrosine phosphorylation by T-cell protein tyrosine phosphatase.

Authors:  Camilla Persson; Catrine Sävenhed; Annie Bourdeau; Michel L Tremblay; Boyka Markova; Frank D Böhmer; Fawaz G Haj; Benjamin G Neel; Ari Elson; Carl-Henrik Heldin; Lars Rönnstrand; Arne Ostman; Carina Hellberg
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

Review 3.  The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury.

Authors:  Z Z Chong; K Maiese
Journal:  Histol Histopathol       Date:  2007-11       Impact factor: 2.303

4.  Inhibition of protein tyrosine phosphatases enhances cerebral collateral growth in rats.

Authors:  Ivo Buschmann; Daniel Hackbusch; Nora Gatzke; André Dülsner; Manuela Trappiel; Markus Dagnell; Arne Ostman; Rob Hooft van Huijsduijnen; Kai Kappert
Journal:  J Mol Med (Berl)       Date:  2014-05-27       Impact factor: 4.599

5.  Assembly of fibronectin fibrils selectively attenuates platelet-derived growth factor-induced intracellular calcium release in fibroblasts.

Authors:  Christopher S Farrar; Denise C Hocking
Journal:  J Biol Chem       Date:  2018-10-15       Impact factor: 5.157

6.  Increased SHP-1 protein expression by high glucose levels reduces nephrin phosphorylation in podocytes.

Authors:  Benoit Denhez; Farah Lizotte; Marie-Odile Guimond; Nina Jones; Tomoko Takano; Pedro Geraldes
Journal:  J Biol Chem       Date:  2014-11-17       Impact factor: 5.157

7.  The tyrosine 343 residue of nucleophosmin (NPM)-anaplastic lymphoma kinase (ALK) is important for its interaction with SHP1, a cytoplasmic tyrosine phosphatase with tumor suppressor functions.

Authors:  Samar A Hegazy; Peng Wang; Mona Anand; Robert J Ingham; Pascal Gelebart; Raymond Lai
Journal:  J Biol Chem       Date:  2010-04-27       Impact factor: 5.157

8.  Stage-specific quantitative changes in renal and urinary proteome during the progression and development of streptozotocin-induced diabetic nephropathy in rats.

Authors:  Vikram Sharma; Kulbhushan Tikoo
Journal:  Mol Cell Biochem       Date:  2013-11-27       Impact factor: 3.396

9.  Pericyte-mediated regulation of capillary diameter: a component of neurovascular coupling in health and disease.

Authors:  Nicola B Hamilton; David Attwell; Catherine N Hall
Journal:  Front Neuroenergetics       Date:  2010-05-21

10.  Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy.

Authors:  Pedro Geraldes; Junko Hiraoka-Yamamoto; Motonobu Matsumoto; Allen Clermont; Michael Leitges; Andre Marette; Lloyd P Aiello; Timothy S Kern; George L King
Journal:  Nat Med       Date:  2009-11-01       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.